MARIA FATIGATI, MD
Legal Medicine in BARTON, Vermont. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: MARIA FATIGATI, MD reported a CMS MIPS final score of 90.0519 out of 100, above the 83.1 national average, and filed 13,409 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
MARIA FATIGATI, MD at a glance
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Vermont
How Legal Medicine compares to other specialties among Vermont providers
Legal Medicine share within Vermont
Legal Medicine is one of the more visible NUCC categories in Vermont
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MARIA FATIGATI, MD's 2023 MIPS final score plotted against the Legal Medicine national average
- MIPS Final Score
- 90.0519/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Legal Medicine) — 90.0519/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Cost dim CMS Cost category
- Specialty volume Legal Medicine US NPIs
90.0519/100 MIPS final score — 7.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Legal Medicine. Cost dim: 50.173.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARIA FATIGATI, MD is a Legal Medicine provider practicing in BARTON, Vermont, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1235193111. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MARIA FATIGATI, MD appears in the CMS NPPES registry as a Legal Medicine provider holding MD credentials at 60 MAPLE LN, BARTON, VT, 05822, with a listed phone of (802) 754-2112. NPI 1235193111 was issued on 04/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FATIGATI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 13,409 prescription claims written by this provider, covering 222 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 2.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.0519/100 for the 2023 performance year, compared with the national average of 83.1.
Legal Medicine is a narrow specialty nationwide, with 1,067 enrolled providers across 51 states and an average of 2,821 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1235193111 |
|---|---|
| Specialty | Legal Medicine |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/17/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARIA FATIGATI, MD's current license status, disciplinary history, and board certifications with the Vermont Board of Medical Practice in Vermont before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 13,409 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 13,429
- Total Day Supply
- 322,529
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $704K
- Generic Drug Cost
- $298K
- Opioid Claims
- 288 (2.1% rate)
- Antibiotic Claims
- 341
Patient Demographics
- Average Patient Age
- 80.9 years
- Avg HCC Risk Score
- 2.00
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 14, 65-74: 37, 75-84: 83, 85+: 88
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Furosemide | 803 |
| Levothyroxine Sodium | 438 |
| Atorvastatin Calcium | 380 |
| Quetiapine Fumarate | 374 |
| Gabapentin | 366 |
| Metoprolol Succinate | 360 |
| Sertraline Hcl | 325 |
| Omeprazole | 308 |
| Eliquis Apixaban | 299 |
| Amlodipine Besylate | 291 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Legal Medicine Overview
How MARIA FATIGATI, MD fits within the Legal Medicine landscape nationally.
MARIA FATIGATI, MD's 13,409 claims are above the specialty average of 2,821.
Nearby Legal Medicine Providers in Vermont
Other clinicians with the same primary specialty enrolled in Vermont, drawn from the same CMS NPPES roster as FATIGATI.
Compare Legal Medicine nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Vermont
Frequently Asked Questions
What is MARIA FATIGATI, MD's specialty? ▼
How much does MARIA FATIGATI, MD prescribe under Medicare Part D? ▼
What is MARIA FATIGATI, MD's Medicare quality score? ▼
Where is MARIA FATIGATI, MD located? ▼
What is MARIA FATIGATI, MD's NPI number? ▼
Does MARIA FATIGATI, MD prescribe more brand-name or generic drugs? ▼
Does MARIA FATIGATI, MD prescribe opioids? ▼
How many Legal Medicine providers are there in the US? ▼
What drugs does MARIA FATIGATI, MD prescribe most often? ▼
Does MARIA FATIGATI, MD accept Medicare? ▼
How can I verify MARIA FATIGATI, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology